/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Biological products, (no diagnostic substances) company · DE · FY ends Dec · -$15M FCF
$1.08
+$0.01 (+0.93%)
EOD Sep 18, 2026
Negative free cash flow of -$13M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$19M
▲ +36.1% YoY
Op. Margin
—
ROIC
-64.01%
▲ +35.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$15M
▲ +47.6% YoY
Op. Cash Flow (TTM)
-$14M
▲ +47.4% YoY
Net Debt
-$16M
Net Cash Position
Cash & Equiv.
$18M
Continue Research
SourceComputed from the 10-Q filed 6 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 7 Aug 2026. How this is calculated.
Price from market data, last close as of 18 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.